Market revenue in 2022 | USD 172.7 million |
Market revenue in 2030 | USD 404.8 million |
Growth rate | 11.2% (CAGR from 2022 to 2030) |
Largest segment | Gene panel, ldt & others |
Fastest growing segment | Gene Panel, LDT & Others |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Gene Panel, LDT & Others |
Key market players worldwide | Illumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multi cancer early detection market will help companies and investors design strategic landscapes.
Gene panel, ldt & others was the largest segment with a revenue share of 100% in 2022. Horizon Databook has segmented the Asia Pacific multi cancer early detection market based on gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific MCED market is expected to grow at a lucrative rate owing to various factors, such as increasing healthcare reforms. Other factors contributing to market growth are improving healthcare infrastructure, a growing population, and rising number of local companies entering the market. Asia Pacific has a large population and high prevalence of cancer.
Thus, usage of screening tests for cancer has increased in the past few years owing to growing government initiatives, such as free screening for cervical cancer, breast cancer, & lung cancer, as well as increasing collaborations between governments, research institutes, & companies for distribution & supply of these tests.
In Asia Pacific, cancer has drawn more attention as a result of demographic shifts brought on by urbanization, aging populations, and economic expansion. High prevalence of health risk factors, such as increasing alcohol & cigarette consumption, poor diets, and sedentary lifestyle, are contributing to the increasing prevalence of cancers.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific multi cancer early detection market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific multi cancer early detection market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account